Robert Owens, MD
Sleep Medicine · San Diego, CANPI 1972589265
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,900 of the $5,066 with a category attached, or 96.7%. 4 manufacturers reported payments, led by Merck at 49.4% of the total. Reporting peaked in 2024 at $4,150 and has fallen 81.9% since, to $750 in 2025.
Across 6 payments — averaging $844.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$3K
- Beckman Coulter, Inc.$2K
- ZOLL Respicardia, Inc.$152
- Getinge USA Sales, LLC$13
Across 6 payments — averaging $6612.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Masimo Corporation$38K
- Novartis$2K
What the payments were for
- Consulting fees$4,90097%
- Food & beverage$1663%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 3 | $2,500 |
| Beckman Coulter, Inc. | 1 | $2,400 |
| ZOLL Respicardia, Inc. | 1 | $152 |
| Getinge USA Sales, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- remede System$152
How this compares
$5,066 in reported general payments places this provider in the 75th percentile of 200 sleep medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sodium Oxybate | 12 | $229,282 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in San Diego
- Lisa ShivesSan Diego$1.4M
- Atul MalhotraSan Diego$771K
- Pegah MashayekhiSan Diego$25K
- Haramandeep SinghSan Ramon$1.1M
- Logan SchneiderStanford$506K
- Tony MasriLos Gatos$327K
- Sam KashaniSanta Monica$221K
- Emmanuel MignotStanford$135K
- Jerome HesterPalo Alto$74K
- Mark BuchfuhrerDowney$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.